Matches in SemOpenAlex for { <https://semopenalex.org/work/W2175122451> ?p ?o ?g. }
- W2175122451 endingPage "e1005263" @default.
- W2175122451 startingPage "e1005263" @default.
- W2175122451 abstract "Ebola virus outbreaks, such as the 2014 Makona epidemic in West Africa, are episodic and deadly. Filovirus antivirals are currently not clinically available. Our findings suggest interferon gamma, an FDA-approved drug, may serve as a novel and effective prophylactic or treatment option. Using mouse-adapted Ebola virus, we found that murine interferon gamma administered 24 hours before or after infection robustly protects lethally-challenged mice and reduces morbidity and serum viral titers. Furthermore, we demonstrated that interferon gamma profoundly inhibits Ebola virus infection of macrophages, an early cellular target of infection. As early as six hours following in vitro infection, Ebola virus RNA levels in interferon gamma-treated macrophages were lower than in infected, untreated cells. Addition of the protein synthesis inhibitor, cycloheximide, to interferon gamma-treated macrophages did not further reduce viral RNA levels, suggesting that interferon gamma blocks life cycle events that require protein synthesis such as virus replication. Microarray studies with interferon gamma-treated human macrophages identified more than 160 interferon-stimulated genes. Ectopic expression of a select group of these genes inhibited Ebola virus infection. These studies provide new potential avenues for antiviral targeting as these genes that have not previously appreciated to inhibit negative strand RNA viruses and specifically Ebola virus infection. As treatment of interferon gamma robustly protects mice from lethal Ebola virus infection, we propose that interferon gamma should be further evaluated for its efficacy as a prophylactic and/or therapeutic strategy against filoviruses. Use of this FDA-approved drug could rapidly be deployed during future outbreaks." @default.
- W2175122451 created "2016-06-24" @default.
- W2175122451 creator A5009591679 @default.
- W2175122451 creator A5019577243 @default.
- W2175122451 creator A5025561095 @default.
- W2175122451 creator A5028322068 @default.
- W2175122451 creator A5031518827 @default.
- W2175122451 creator A5039967113 @default.
- W2175122451 creator A5042358991 @default.
- W2175122451 creator A5067855810 @default.
- W2175122451 creator A5073016612 @default.
- W2175122451 creator A5073957982 @default.
- W2175122451 creator A5083946123 @default.
- W2175122451 creator A5084839482 @default.
- W2175122451 date "2015-11-12" @default.
- W2175122451 modified "2023-10-10" @default.
- W2175122451 title "Interferon-γ Inhibits Ebola Virus Infection" @default.
- W2175122451 cites W1266297804 @default.
- W2175122451 cites W140877157 @default.
- W2175122451 cites W1496474841 @default.
- W2175122451 cites W1504643362 @default.
- W2175122451 cites W1510386142 @default.
- W2175122451 cites W1559656254 @default.
- W2175122451 cites W1603558825 @default.
- W2175122451 cites W1760776415 @default.
- W2175122451 cites W1834981029 @default.
- W2175122451 cites W1966282784 @default.
- W2175122451 cites W1968345770 @default.
- W2175122451 cites W1969735667 @default.
- W2175122451 cites W1971108104 @default.
- W2175122451 cites W1971189758 @default.
- W2175122451 cites W1975375203 @default.
- W2175122451 cites W1975525323 @default.
- W2175122451 cites W1975764372 @default.
- W2175122451 cites W1981692189 @default.
- W2175122451 cites W1984632540 @default.
- W2175122451 cites W2015627525 @default.
- W2175122451 cites W2015999301 @default.
- W2175122451 cites W2021378345 @default.
- W2175122451 cites W2030622694 @default.
- W2175122451 cites W2030865745 @default.
- W2175122451 cites W2034662297 @default.
- W2175122451 cites W2034739637 @default.
- W2175122451 cites W2035509260 @default.
- W2175122451 cites W2037151930 @default.
- W2175122451 cites W2038501005 @default.
- W2175122451 cites W2041539972 @default.
- W2175122451 cites W2054493435 @default.
- W2175122451 cites W2056956872 @default.
- W2175122451 cites W2058277625 @default.
- W2175122451 cites W2061074304 @default.
- W2175122451 cites W2061896947 @default.
- W2175122451 cites W2062623649 @default.
- W2175122451 cites W2067533148 @default.
- W2175122451 cites W2070855360 @default.
- W2175122451 cites W2073246940 @default.
- W2175122451 cites W2077205343 @default.
- W2175122451 cites W2077602553 @default.
- W2175122451 cites W2078646756 @default.
- W2175122451 cites W2078844752 @default.
- W2175122451 cites W2079928928 @default.
- W2175122451 cites W2081610560 @default.
- W2175122451 cites W2086751382 @default.
- W2175122451 cites W2098811581 @default.
- W2175122451 cites W2098970996 @default.
- W2175122451 cites W2099471944 @default.
- W2175122451 cites W2100303008 @default.
- W2175122451 cites W2103329564 @default.
- W2175122451 cites W2104062423 @default.
- W2175122451 cites W2106430003 @default.
- W2175122451 cites W2107446952 @default.
- W2175122451 cites W2109176931 @default.
- W2175122451 cites W2110877444 @default.
- W2175122451 cites W2110951885 @default.
- W2175122451 cites W2113174452 @default.
- W2175122451 cites W2121706409 @default.
- W2175122451 cites W2122121966 @default.
- W2175122451 cites W2123699288 @default.
- W2175122451 cites W2124727351 @default.
- W2175122451 cites W2127087142 @default.
- W2175122451 cites W2127228010 @default.
- W2175122451 cites W2129860769 @default.
- W2175122451 cites W2130901375 @default.
- W2175122451 cites W2135264287 @default.
- W2175122451 cites W2136920638 @default.
- W2175122451 cites W2138127993 @default.
- W2175122451 cites W2138838687 @default.
- W2175122451 cites W2140380746 @default.
- W2175122451 cites W2143353745 @default.
- W2175122451 cites W2144206275 @default.
- W2175122451 cites W2146432219 @default.
- W2175122451 cites W2147579012 @default.
- W2175122451 cites W2151536732 @default.
- W2175122451 cites W2152041346 @default.
- W2175122451 cites W2153306993 @default.
- W2175122451 cites W2153398168 @default.
- W2175122451 cites W2155366992 @default.
- W2175122451 cites W2156268169 @default.